Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 0.58 |
| ▸ | GPR132 | Q9UNW8 | 6/20 | 0.57 |
| ▸ | GPR34 | Q9UPC5 | 8/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.49 |
| ▸ | CMKLR2 | P46091 | 1/20 | 0.49 |
| ▸ | CMKLR1 | Q99788 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1122720 | 0.94 | GAA (0.59) | PTPN1GPR132GPR34GAARAB9A | |
| SCHEMBL1122788 | 0.91 | GPR132 (0.62) | PTPN1GPR132GPR34GAARAB9A | |
| SCHEMBL1123459 | 0.87 | GAA (0.67) | PTPN1GPR132GPR34GAARAB9A | |
| SCHEMBL18114395 | 0.84 | GPR132 (0.81) | PTPN1GPR132GPR34PPARGCMKLR2 | |
| SCHEMBL1122641 | 0.83 | PTPN1 (0.77) | PTPN1GPR132GPR34GAARAB9A | |
| SCHEMBL1123300 | 0.83 | GPR132 (0.59) | PTPN1GPR132GPR34PPARGCMKLR2 | |
| SCHEMBL6030433 | 0.82 | GPR132 (0.65) | PTPN1GPR132GPR34GAARAB9A | |
| SCHEMBL1123310 | 0.81 | PTPN1 (0.61) | PTPN1GPR132GPR34GAARAB9A | |
| SCHEMBL1122875 | 0.81 | GPR132 (0.79) | PTPN1GPR132GPR34PPARGCMKLR2 | |
| SCHEMBL27658925 | 0.81 | GPR132 (0.79) | PTPN1GPR132GPR34PPARGCMKLR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060160894-A1 | Benzamides as ppar modulators | LABORATORIOS S.A.L.V.A.T.,S.A. (ES) | 2006-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060160894-A1 | Benzamides as ppar modulators | PPARD, PPARA, PPARG | PTPN1 2708/4885GPR132 122/4885GPR34 166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.